RNAs may help identify stage II colon cancer patients who could benefit from chemotherapy following surgery
The decision to treat patients with stage II colon cancer with adjuvant chemotherapy remains controversial. Therefore, there is an urgent need to identify reliable prognostic biomarkers that may be used to identify which ...
Jul 8, 2024
0
0